Free Longevity Report • PDF
The $600 Billion Blind Spot
What the 2024 PwC Menopause Report didn't tell your doctor — and the 30-year downstream cost of osteoporosis, cardiovascular disease, and cognitive decline that 70% of providers are untrained to address.
What's inside the report
- The PwC market map: why a $600B+ downstream menopause market still has "no coordinated name or investment behind it."
- The doctor-deficit data: why fewer than 30% of internal medicine residents receive menopause training.
- The three downstream consequences that compound over 30 years: bone density, vascular tissue, cognition.
- The Estrogen-Collagen-Regeneration (ECR) deficit framework — kindr's clinical model for upstream intervention.
- How peptide therapy, timing-aware HRT, and targeted nutraceuticals reduce downstream risk when started in the 10-year window.
- A self-assessment cheat sheet you can take to your physician.
Authored by the clinical team at kindr Health (NPI 1609792902). Educational use only — not a substitute for individualized medical advice.
Ready to act on it? The Kindr Tissue Clock™ is the upstream diagnostic tool referenced in the report — 60 seconds, free, and gives you a 30-year downstream risk profile for bone, heart, and brain.